혈청 분리 겔 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Serum Separation Gels Market size is expected to reach USD 11.84 Billion in 2034 from USD 6.65 Billion (2025) growing at a CAGR of 6.62% during 2026-2034.

The Global Serum Separation Gels market has witnessed steady growth due to rising demand for efficient blood sample processing in diagnostic laboratories. These gels are essential in clinical testing, enabling clear separation of serum from blood cells. Increasing prevalence of chronic diseases and routine health screenings have boosted market expansion. Growth in healthcare infrastructure further supports demand globally.

Growth drivers include technological advancements in diagnostic equipment and automation. Laboratories require reliable sample preparation solutions to ensure accuracy and efficiency. Expanding hospital networks and research institutions also contribute to rising consumption. Additionally, growing awareness about preventive healthcare strengthens testing frequency.

Future prospects appear promising as diagnostic testing volumes increase worldwide. Innovations in gel composition and improved compatibility with advanced analyzers will enhance performance. Emerging economies investing in healthcare modernization offer new growth avenues. The market is expected to expand steadily with rising global diagnostic needs.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Application

• Clinical Diagnostics
• Blood Banking
• Research
• Pharmaceuticals

By Product Type

• Serum Separation Gel Integrated With Tube
• Serum Separation Gel Without Tubes

By End User

• Hospitals
• Diagnostic Laboratories
• Blood Banks
• Research Institutions
• Pharmaceutical Companies

COMPANIES PROFILED

• BD, Greiner BioOne, Sarstedt AG Co KG, Terumo Corporation, Thermo Fisher Scientific Inc, Fresenius Kabi AG, Qiagen NV, Nipro Corporation, Cardinal Health Inc, BioRad Laboratories
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL SERUM SEPARATION GELS MARKET: BY APPLICATION 2022-2034 (USD MN and Units)

• 4.1. Market Analysis, Insights and Forecast Application
• 4.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.3. Blood Banking Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.4. Research Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 4.5. Pharmaceuticals Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 5. GLOBAL SERUM SEPARATION GELS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN and Units)

• 5.1. Market Analysis, Insights and Forecast Product Type
• 5.2. Serum Separation Gel Integrated With Tube Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 5.3. Serum Separation Gel Without Tubes Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 6. GLOBAL SERUM SEPARATION GELS MARKET: BY END USER 2022-2034 (USD MN and Units)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.3. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.4. Blood Banks Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.5. Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)
• 6.6. Pharmaceutical Companies Estimates and Forecasts By Regions 2022-2034 (USD MN and Units)

Chapter 7. GLOBAL SERUM SEPARATION GELS MARKET: BY REGION 2022-2034(USD MN and Units)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.2.1 By Application
  • 7.2.2 By Product Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.3.1 By Application
  • 7.3.2 By Product Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.4.1 By Application
  • 7.4.2 By Product Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.5.1 By Application
  • 7.5.2 By Product Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN and Units)
  • 7.6.1 By Application
  • 7.6.2 By Product Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL SERUM SEPARATION GELS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 BD
  • 9.2.2 Greiner Bio-One
  • 9.2.3 Sarstedt AG & Co. KG
  • 9.2.4 Terumo Corporation
  • 9.2.5 Thermo Fisher Scientific Inc
  • 9.2.6 Fresenius Kabi AG
  • 9.2.7 Qiagen NV
  • 9.2.8 Nipro Corporation
  • 9.2.9 Cardinal Health Inc
  • 9.2.10 Bio-Rad Laboratories